BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 14, 2009
View Archived Issues
ZymoGenetics divulges novel antipsoriatic ztnfr14 antagonists
Read More
New humaneered anti-factor B antibodies reported in recent Taligen patent
Read More
GSK reports novel AMPA receptor modulators with antipsychotic properties
Read More
Recent Merck & Co. patent discloses a new series of polypeptides with antibacterial properties
Read More
New Chlamydia vaccine patented by the Thrombosis Research Institute
Read More
UCB and Wilex sign strategic alliance to develop UCB's preclinical oncology portfolio
Read More
Array BioPharma initiates phase I clinical trial for MEK inhibitor ARRY-300
Read More
TopiGen reports phase II TPI-ASM-8 results in asthma patients
Read More
Cara commences phase II proof-of-concept trial in acute postoperative pain
Read More
Cytokinetics presents update on muscle biology research and development programs
Read More
Genzyme and Isis commence several mipomersen trials
Read More
Solace initiates phase IIa glial cell modulator trial in postherpetic neuralgia
Read More
InterMune reports results from ITMN-191 triple combination study
Read More
Ardea presents positive results from phase I RDEA-594 study
Read More
Synvista Therapeutics progresses phase II clinical trial program for alagebrium
Read More
Clinical investigation of Diasome's hepatic-directed vesicle-insulin advances
Read More
Mechanism behind leptin resistance clarified, possible treatments tested in vivo
Read More
FK-1706 shows promise in painful diabetic neuropathy
Read More
Cubist and Alnylam form strategic collaboration for RNAi therapeutics targeting RSV
Read More
Medtronic to acquire Ablation Frontiers for USD 225 million
Read More
Esteve signs research partnership for development of AIDS vaccine
Read More
Pharmasset and Roche agree with FDA on final design of phase IIb trial of R-7128 in HCV
Read More
ISMB authorizes completion of BioLineRx's phase I/II study of BL-1040 in MI
Read More
Novartis initiates dosing in phase IIb trial of Albuferon in chronic hepatitis C
Read More
Anthera completes enrollment and dosing in FRANCIS clinical trial of varespladib for ACS
Read More